Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback
Neurotype Inc. has raised $329K in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Neurotype Inc.'s investors include National Institutes of Health, Yale University, National Institute on Drug Abuse (NIDA), Minnesota Department of Employment and Economic Development.
Neurotype Inc. is headquartered in Minneapolis, United States.
Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback
Neurotype Inc. is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurotype Inc. — Funding & Investors." VCBacked, September 30, 2023, https://www.vcbacked.co/company/neurotype-inc. Accessed July 19, 2026.
VCBacked. (2023). Neurotype Inc. — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neurotype-inc
{{cite web |title=Neurotype Inc. — Funding & Investors |url=https://www.vcbacked.co/company/neurotype-inc |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated